American Red Cross: Evolution of vCJD Donor Deferral Criteria and Blood Supply Peter L. Page, MD Senior Medical Officer Biomedical Headquarters TSEAC February.

Slides:



Advertisements
Similar presentations
The European Law Students Association Albania ˙ Austria ˙ Azerbaijan ˙ Belgium ˙ Bosnia and Herzegovina ˙ Bulgaria ˙ Croatia ˙ Cyprus ˙ Czech Republic.
Advertisements

Magician or Math-a-magician?. Math Magic Math Magic – Trick #1 Pick a number… any number! (keep it a secret though) Add 1 to that number Multiply by.
Communication ICM Bodrum, 21st of October The European Law Students’ Association Albania ˙ Austria ˙ Azerbaijan ˙ Belgium ˙ Bosnia and Herzegovina.
UNIVERSITY OF JYVÄSKYLÄ INTERNATIONAL COOPERATION.
Longitude/Latitude Prime Meridian/Equator Oceans Tropics Continents
Eastern Europe: Poland, Lithuania, Latvia, Estonia, Russia, Ukraine, Romania, Bulgaria, Macedonia, Albania, Belarus, Bosnia and Herzegovina, Croatia, Slovenia,
Political Map of Europe. 1. British Isles 2. Nordic Nations 3. Central Western Europe 4. Mediterranean Europe 5. Eastern Europe.
ELSA Law Schools LXVI ICM, Bodrum, October 2014.
Delegations III KAM, Bratislava 4th to 8th September 2013.
Knowledge Management LXV International Council Meeting Qawra, Malta 16 th - 23 rd of March 2014.
Study Visits ICM Croatia, Opatija, 27th October to 3th November 2013.
Transmissible Spongiform Encephalopathies Advisory Committee 23 rd Meeting Gaithersburg, MD – August 1, 2011 CJD and vCJD Donor Policies: Blood and Blood.
The Geography Challenge
Institutional Visits IV KAM Prague, 3 rd to 7th September.
ELSA Shop(ping) – Spring SALE! LXV International Council Meeting Qawra, Malta 16 th - 23 rd of March 2014.
Knowledge Management and Transition ICM Cluj-Napoca, 24th April 2015.
ELSA Shop(ping) LXIV International Council Meeting Opatija, Croatia October 28 th - November 3 rd 2013.
Area Definition III KAM,Bratislava. The European Law Students’ Association Albania ˙ Austria ˙ Azerbaijan ˙ Belgium ˙ Bosnia and Herzegovina ˙ Bulgaria.
ELSA Law Schools ICM Cluj-Napoca, 21st April 2015.
Grant case study LXVII International Council Meeting 19th – 25th April, Cluj-Napoca Romania.
Make it Smart&Creative ICM Cluj-Napoca, 21st April 2015.
1 U.S. vCJD Donor Screening: Human Cells, Tissues, and Cellular and Tissue- Based Products (HCT/Ps) Melissa A Greenwald, MD CAPT, U.S. Public Health Service.
EUROPE.
KAM Prague 3 rd -7 th September AA Workshop Studies Abroad Projects Embrace cultural diversity!
Doing Business in Europe Bay Area CITD Seminar Series Tuesday, September 21st, 2004 Kemarra Inc. - Key Marketing Resources & Associates San Francisco USA.
ICM Bodrum 24 th October AA Workshop Legal Research Group.
American Red Cross, vCJD Donor Deferral Criteria, and Blood Supply Peter L. Page, MD Senior Medical Officer Biomedical Headquarters TSEAC 06/27/02.
NextLastEurope. NextLastEurope  The region of Europe is the area on the map shaded dark purple. Europe.
Europe Research PowerPoint Each group (2-3) must choose two countries from Europe and create a PPT that teaches their classmates about those nations.
Institutional Visit LXV International Council Meeting Qawra, Malta 16 th - 23 rd of March 2014.
ELSA as the Franchise? LXV International Council Meeting Qawra, Malta 16 th - 23 rd of March 2014.
EXTREME MAKEOVER Members’ Magazine LXIV International Council Meeting Opatija, Croatia October 28 th - November 3 rd 2013.
Map - Region 3 Europe.
ELSA Summer Law Schools IV KAM Prague, 3rd to 7th September 2014.
Which role is yours? ADV and Promotion of ELSA projects/events LXIV International Council Meeting Opatija, Croatia October 28 th - November 3 rd 2013.
KAM Prague 3 rd -7 th September AA Workhsop Law Review.
European Federation of Public Service Unions (EPSU)
Europe. Albania AL Austria Belarus Belgium.
Promotion of AA Projects 2015/2016 ICM Batumi 18 th -25 th October 2015.
Delegations LXV International Council Meeting Qawra, Malta 16 th - 23 rd of March 2014.
RESULTS OF THE SURVEY ON MUNICIPALITY AUDIT Otilija Pranevičiūtė, Senior Officer, International Relations Division 6 October 2015.
Social Studies: Europe & Russia Lesson 34 Practice & Review
E u r o g u i d a n c e A Network of National Resource and Information Centres for Guidance Established in 1992.
The 19 th of June 1990 : The Schengen Implementing Convention has been signed by : - Germany - Belgium - France - Luxembourg - Netherlands Calendar.
Computer Class – Summer 20092/21/2016 3:45 AM European Countries Albania Andorra Austria Belarus Belgium Bosnia and Herzegovina Bulgaria Croatia Czech.
Geography Review On Map 1, please identify: -Spain -France -England -Russia -Ottoman empire -Persia -China -Mughal India -Songhai Empire.
The European Law Students’ Association Albania ˙ Austria ˙ Azerbaijan ˙ Belgium ˙ Bosnia and Herzegovina ˙ Bulgaria ˙ Croatia ˙ Cyprus ˙ Czech Republic.
LXVI Internationl Council Meeting Turkey 19th – 26th of October 2014 Academic Activites Workshop Monday 20th of October –
Table 1. Number and rate of reported confirmed syphilis cases per population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate,
Table 1. Number and rate of Legionnaires’ disease cases per population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate, C: case-based.
CONFIDENTIAL 1 EPC, European Union and unitary patent/UPC EPC: yes EEA: no EU: no (*) (*) Also means no unitary patent Albania, Macedonia, Monaco, San.
France Ireland Norway Sweden Finland Estonia Latvia Spain Portugal Belgium Netherlands Germany Switzerland Italy Czech Rep Slovakia Austria Poland Ukraine.
Best Sustainable Development Practices for Food Security UV-B radiation: A Specific Regulator of Plant Growth and Food Quality in a Changing Climate The.
AllianceSymbol Alliance 1:  Strong military  Weak economy  Unlimited government (dictator) Alliance 2:  Strong military  Strong economy  Limited.
EUROPEAN UNION – MAKING OFF European Economic Community
DISTRIBUTION AUTOMATIC - GENERATION
Figure 1. Number of reported hantavirus infection cases, EU/EEA, 2014
Table 1. Number and rate of reported confirmed syphilis cases per 100 000 population by country and year, EU/EEA, 2010–2014 Country
Statistics on crime and criminal justice, Eurostat Working group meeting, 19–20 February 2009, Luxemburg Council of Europe Annual Penal Statistics – 2006.
The European Parliament – voice of the people
The European Parliament – voice of the people
HEDIC Health expenditures by diseases and conditions
Намалување на загадувањето на воздухот со електромобилност
European survey respondents by region.
EU: First- & Second-Generation Immigrants
Adriatic Persian Gulf Map Test #1 Answers.
European Union Membership
Adoption, adaptation and applicability of the Global Curriculum in Medical Oncology. Adoption, adaptation and applicability of the Global Curriculum in.
Adriatic Persian Gulf Map Test #1 Answers.
European representation of respiratory critical care HERMES participants. European representation of respiratory critical care HERMES participants. Countries.
Presentation transcript:

American Red Cross: Evolution of vCJD Donor Deferral Criteria and Blood Supply Peter L. Page, MD Senior Medical Officer Biomedical Headquarters TSEAC February 20, 2003

Background 1 §March 2000: ARC initiated first vCJD deferrals §Early 2001: ARC developed vCJD geographic donor deferral criteria, based upon concern and uncertainty about upcoming evolution of epidemic, stating policy would be reconsidered annually and as new data accrue

Background 2 §October 2001: ARC implemented its initial deferral criteria §January 2002: FDA issues final guidance to take effect 06/02 and 11/02 §Spring 2002: ARC decides to relax criteria regarding presence in the UK after 1996 (actual implementation TBD in 2003)

1 Final Guidance 1/9/02 2 Albania, Austria, Belgium, Bosnia-Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Republic of Ireland, Italy, Liechtenstein, Luxembourg, Macedonia, Netherlands, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, Switzerland, Federal Republic of Yugoslavia. 3 Germany, Italy, Netherlands, Switzerland, Austria, Belgium, Spain, Republic of Ireland, Portugal, Denmark, Luxembourg and Liechtenstein Quick-reference summary of vCJD-related geographic donor deferral criteria as of 1/9/02 AgencyIn Effect:UKFrance Europe Other Than FranceOther Countries Special Rules for US Military Base Personnel FDA11/99-5/02  6 months, None ARC11/99-9/01  6 months, None ARC10/01 forward  3 months, 1980-present  6 months, 1980-present  6 months, 1980-present, all countries Gibraltar and Falklands same as UK; Oman same as Europe Same as country in which military base resides. NOTE: This implies there is not deferral for military staff on bases in Turkey FDA 1 6/02-10/02  3 months,  5 years, 1980-present NoneGibraltar and Falklands same as UK  6 months from for Germany, UK, Belgium and Netherlands;  6 months from for Turkey, Spain, Portugal and Italy FDA 1 11/02 forward  3 months,  5 years, 1980-present  5 years, present, selected countries only 2, except Source Plasma donors Gibraltar and Falklands same as UK  6 months from for Germany, UK, Belgium and Netherlands;  6 months from for Turkey, Spain, Portugal and Italy DoDSame as FDA  6 months from for bases anywhere in Europe or Turkey Hema Quebec 9/01 forward  1 month, 1980-present  3 months, 1980-present  6 months, Western Europe only 3 None CBS10/01 forward  3 months, 1980-present  3 months, 1980-present  5 years, present, Western Europe only 3 None ARCXX/03 forward  3 months, Same

1. UK Deferral Criteria Current ARC criteria:  3 months, 1980-present Upcoming ARC criteria:  3 months, FDA criteria:  3 months, §ARC to change to FDA’s criteria (cut off at end of 1996) §Rationale: Food chain controls implemented in UK by 1996 are now (2002) deemed to have been effective and sufficient. §Results: l ARC consistent with FDA on this issue l Individuals’ presence in the UK after 1996, after food controls in place, would not effect eligibility

2. Rest of Europe Deferral Criteria Ongoing ARC criteria:  6 months for all countries FDA criteria (11/02):  5 years for most countries §ARC Plan: To be re-evaluated in Spring ‘03 §Rationale: Continuing lack of active surveillance and effective food controls in some of those countries now better appreciated in 2002 §Results: l No operational change for ARC; avoid complexity of dealing with various U.S. bases

Differences in vCJD geographic deferrals: Current and upcoming ARC and current FDA ARCFDA Oman included US Military bases in specified European countries Yes ‘80-present 6 months Whole country 1.3 months in UK from‘80-Present ’80-’96* 2.Time in Europe from present 6 months (All European countries) No ‘80-‘90 or -‘96 6 months Only bases ‘80-‘96 5 years (Some European countries) *Date of change TBD in 2003

ARC Experience §Donor deferrals*, & blood collections vs. goal §Blood distribution & inventory *DONOR DEFERRALS = PRESENTING VOLUNTEERS TURNED AWAY FROM DONATION--WHICH DOES NOT INCLUDE INDIVIDUALS WHO DO NOT PRESENT AT ALL, HAVING HEARD ELSEWHERE THAT THEY WOULD BE TURNED AWAY.

vCJD Deferrals in October 2001 Percent Deferred re vCJD By Day  6 months UK Bovine insulin  3 months UK  6 months rest of Europe Bovine insulin 2001

vCJD Deferrals September 01– March 02 Percent Deferred By Week

Puerto Rico American Red Cross Blood Services Regions by Region Code and Customer Business Unit (CBU) South Central CBU Western CBU North Central CBU North Atlantic CBU

vCJD Specific Donor Deferral Rates by Region For 03/01 and 10/15-12/14/01 North Atlantic North Central South Central Western Region Code CBU: 3/01≥ 6 months UK, in place for 12 months 10/15-12/14/01≥ 3 months UK, ≥ 6 months Europe, newly implemented

vCJD Specific Donor Deferral Rates by Region For 10/15-12/14/01, 3/02 and 7-12/02 North Atlantic North Central South Central Western Region Code CBU: 3/01≥ 6 months UK, in place for 12 months 10/15-12/14/01≥ 3 months UK, ≥ 6 months Europe, newly implemented 3/02≥ 3 months UK, ≥ 6 months Europe, in place for 6 months

Summary: vCJD Deferrals by Region and Time Time Period Number of Donors Deferred re vCJD per Month March /15 – 12/14/01*5,631 March 02 ARCFDA RangeAverage Regional Donor vCJD Deferral Rate 0.00% %0.06% 0.21% %0.88% 0.25% %0.62%3,764 *New criteria started 10/15/01 **Lessening of UK deferrals not after implemented December 02**0.08% %0.38%2,108

Deferrals and Collections Deferral Rate All Donors, All Reasons By Month WB Allogeneic Collections By Month August 2000 Switch from ear to finger sample, +4.5% deferral for hemoglobin

Distribution and Inventory Average Net Daily Distribution By Month Average Daily Inventory By Month

Summary §When anticipated and planned for, new donor deferral criteria should be accommodated by increased donor recruitment and collection efforts, albeit expensive §After the increase in deferrals from a new measure, there is culling, and the deferral rate for that reason then drops §Deferral for TSE concerns is only one of several recently added deferral criteria, each of which increases the cost of donor recruitment and collection to try to make up for it §More regular volunteer blood donations continue to be needed to prevent seasonal shortages and to develop a reserve for unanticipated occurrences